| HTXD: Treatment: ARV Drugs |
$341,919,910 |
| HTXS: Treatment: Adult Treatment |
$292,853,156 |
| HKID: Care: Orphans and Vulnerable Children |
$143,011,759 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission |
$125,750,300 |
| HLAB: Laboratory Infrastructure |
$113,708,501 |
| HBHC: Care: Adult Care and Support |
$102,615,846 |
| OHSS: Health Systems Strengthening |
$98,692,393 |
| HVCT: Testing: HIV Testing and Counseling |
$94,338,654 |
| HVMS: Management and Operations |
$94,322,387 |
| HVOP: Sexual Prevention: Other Sexual Prevention |
$65,045,390 |
| HVSI: Strategic Information |
$53,610,153 |
| HVTB: Care: TB/HIV |
$32,648,715 |
| PDTX: Treatment: Pediatric Treatment |
$30,705,307 |
| PDCS: Care: Pediatric Care and Support |
$19,551,851 |
| HMBL: Biomedical Prevention: Blood Safety |
$13,307,830 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful |
$10,691,977 |
| HMIN: Biomedical Prevention: Injection Safety |
$8,558,766 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision |
$0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use |
$0 |
